News

  1. 12/09/2013 Orphan Drug Model to be Debated by Catalent Expert at FDA/CMS Summit

  2. 12/08/2013 Extractables and Leachables for Parenteral and Opthalmic

  3. 12/05/2013 Catalent & Redwood Bioscience present Next Generation Antibody Drug Conjugates

  4. 11/20/2013 Pharmacyclics and Catalent Solidify Partnership on Imbruvica™

  5. 11/19/2013 Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal

  6. 11/11/2013 Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business

  7. 11/06/2013 New Interactive Web Tool Helps Innovators

  8. 11/04/2013 New Drug Delivery Technologies Presented at AAPS

  9. 10/16/2013 Catalent Presents New Technologies at CPhI

  10. 10/14/2013 Compelling New Data on Next Generation Antibody Drug Conjugates

  11. 10/08/2013 Catalent Acquires Relthy to Expand South American Softgel Business

  12. 09/25/2013 Catalent Announces Expansion of Optimelt™ Hot Melt Extrusion

  13. 09/22/2013 Catalent Participates in Inaugural Blackstone Veterans Hiring Summit

  14. 09/19/2013 The Institute Appoints Professor Claus-Michael Lehr to Advisory Board

  15. 09/16/2013 Catalent Pharma Solutions and Supernus Partner for Supply of Trokendi XR™

  16. 09/11/2013 Catalent Experts to Present Collaborative Product Development at EPTM

  17. 09/08/2013 Catalent Appoints First President of Asia Pacific

  18. 09/03/2013 Catalent Applied Drug Delivery Institute Announces European Educational Event

  19. 07/15/2013 Advances in Modified & Controlled Release - Catalent at 40th Annual CRS Meeting

  20. 07/09/2013 Catalent and Biota Pharmaceuticals Expand Their Alliance

  21. 07/07/2013 Catalent Creates New Advanced Delivery Technologies Business Unit

  22. 06/11/2013 Catalent Breaks Ground of its Winchester, KY CR Manufacturing Facility

  23. 05/15/2013 Worldwide Competition Recognizes Next-Generation Scientific Talent

  24. 05/12/2013 Catalent Wins Two Prestigious Process Excellence Awards

  25. 05/09/2013 Omega-3 Trends and Innovations at Vitafoods

  26. 04/24/2013 Catalent Announces Opening of New Single-Use Biomanufacturing Center

  27. 04/22/2013 Company Receives Two PEX Network European Awards Nominations

  28. 04/18/2013 Catalent Experts Exhibit and Present at BIO and Interphex 2013

  29. 04/15/2013 Catalent Announces Two Senior Appointments to Drive Growth in China

  30. 04/09/2013 Catalent Biologics Expands Into ADCs Through Exclusive License

  31. 03/25/2013 catalent leader to chair discussions on optimizing clinical operation in china

  32. 03/19/2013 Catalent Australia and Medipharm Partner to Supply Malaysian Market

  33. 03/18/2013 Experts Consider Challenging Tech Transfers at Dusseldorf Pharma Congress

  34. 03/06/2013 Applied Drug Delivery Institute Welcomes Accomplished Life Sciences Leader

  35. 03/04/2013 Catalent Quality Development Leader to Present at China Clinical Trials

  36. 02/25/2013 Speeding Drug Development Through Use of High Yield Stable GPEx® Technology

  37. 02/24/2013 Catalent Presents Drug Delivery Strategies at Improving Solubility in Philly

  38. 01/29/2013 Catalent Applied Drug Delivery Institute Holds 2nd Global Academic Competition

  39. 01/28/2013 The Impact of Emerging Bioassay Technologies Presented at WCBP Conference

  40. 01/22/2013 Presenting Better Treatments Through Bioavailability Enhancement

  41. 01/21/2013 Accelerating Development from CDNA Sequence to Master Cell Bank Candidate

  42. 01/09/2013 Catalent Makes Investment to Expand Inhalation Capabilities in RTP, NC

  43. 01/07/2013 Catalent and Aegerion Partner on Launch of Newly FDA Approved Juxtapid™